Evaluating the feasibility, acceptability and effectiveness of integrating mentalization principles into cognitive behavioural treatment for childhood anxiety disorders.

Not Applicable

Completed

• Conditions: Childhood Anxiety Disorders; Mental Health - Anxiety

• Registration Number: ACTRN12622001068752
• Lead Sponsor: Swinburne Univeristy of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-02
• Study Completion: 2023-08-31
• Last Update Posted: 26 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Parents with a child aged 6-11 years of age with an elevated anxiety score (T-Score equal to or greater than 60) in one or more anxiety disorder on the parent reported Spence’s Children’s Anxiety Scale - Parent Report (SCAS-P) and anxiety disorder diagnosis on the MINI Psychiatric Interview for children.

Exclusion Criteria

Exclusion criteria includes children with a current primary diagnosis of PTSD/Conduct/Depression.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Child anxiety symptoms as measured by the Spence Children's Anxiety Scale - Parent Report (SCAS-P).[ Baseline, completion of treatment (primary timepoint) and 12 weeks post-intervention completion.];Parent self-efficacy as measured using an adapted version of the Brief Parental Self-Efficacy Scale (BPSES)[ Baseline, completion of treatment (primary time-point) and 12 weeks post-intervention completion.]

Secondary Outcome Measures

Name	Time	Method
Parent mentalization as measured by the Parental Reflective Functioning Questionnaire (PRFQ).[ Baseline, completion of treatment and 12 weeks post-intervention completion.];Feasibility as measured by the number of participants recruited (number of participants recruited as assessed by study recruitment logs), participant retention and participant drop out (number of participants who completed the program and the number of participants who ceased treatment before completion as per the participant logs). [ Baseline and completion of treatment ];Accessibility as measured by the 5-item impact/impairment score on the Strengths and Difficulties Questionnaire (SDQ)[ Baseline, completion of treatment and 12 week post-intervention completion. ]